Innate Pharma SA Cash Flows From Used In Financing Activities
Innate Pharma SA (IPHYF) reported Cash Flows From Used In Financing Activities of EUR 6.07 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-04-01
| Period end | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 12 month | Cash Flows From Used In Financing Activities 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 6.07M EUR 20-F · filed 2026-04-01 | ||
| 2025-06-30 | 10.48M EUR 6-K · filed 2025-09-17 | ||
| 2024-12-31 | -6.01M EUR 20-F · filed 2026-04-01 | ||
| 2024-06-30 | -4.33M EUR 6-K · filed 2025-09-17 | ||
| 2023-12-31 | -1.97M EUR 20-F · filed 2026-04-01 | ||
| 2023-06-30 | -1.25M EUR 6-K · filed 2024-09-12 | ||
| 2022-12-31 | -1.83M EUR 20-F · filed 2025-04-30 | ||
| 2022-06-30 | -960.00K EUR 6-K · filed 2023-09-14 | ||
| 2021-12-31 | 26.82M EUR 20-F · filed 2024-04-04 | 26.82M EUR 20-F · filed 2022-04-04 | |
| 2021-06-30 | -1.23M EUR 6-K · filed 2022-09-15 | ||
| 2020-12-31 | -1.18M EUR 20-F · filed 2023-04-06 | ||
| 2020-06-30 | -1.20M EUR 6-K · filed 2021-09-15 | ||
| 2019-12-31 | 77.77M EUR 20-F · filed 2022-04-04 | ||
| 2018-12-31 | 61.22M EUR 20-F · filed 2021-04-27 | ||
| 2017-12-31 | 915.00K EUR 20-F · filed 2020-04-24 |